WS
MRNA icon

Wedbush Securities’s Moderna MRNA Stock Holding History

Wedbush Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,902
Closed -$245K – 1157
2024
Q4 		$245K Buy
5,902
+1,686
+40% +$80.6K 0.01% 929
2024
Q3 		$282K Sell
4,216
-17
-0.4% -$1.56K 0.01% 830
2024
Q2 		$503K Sell
4,233
-382
-8% -$48.3K 0.02% 625
2024
Q1 		$492K Sell
4,615
-1,264
-22% -$127K 0.02% 645
2023
Q4 		$585K Buy
5,879
+241
+4% +$20.3K 0.03% 502
2023
Q3 		$582K Sell
5,638
-265
-4% -$29.6K 0.03% 469
2023
Q2 		$717K Buy
5,903
+110
+2% +$14.7K 0.03% 420
2023
Q1 		$890K Sell
5,793
-11
-0.2% -$1.81K 0.04% 351
2022
Q4 		$1.04M Sell
5,804
-241
-4% -$39.4K 0.06% 293
2022
Q3 		$715K Sell
6,045
-422
-7% -$64K 0.04% 379
2022
Q2 		$924K Sell
6,467
-1,005
-13% -$144K 0.05% 313
2022
Q1 		$1.29M Buy
7,472
+392
+6% +$66K 0.06% 278
2021
Q4 		$1.8M Buy
7,080
+1,238
+21% +$362K 0.08% 209
2021
Q3 		$2.25M Buy
5,842
+422
+8% +$156K 0.11% 159
2021
Q2 		$1.27M Sell
5,420
-2,133
-28% -$381K 0.06% 302
2021
Q1 		$989K Sell
7,553
-4,200
-36% -$609K 0.05% 334
2020
Q4 		$1.23M Buy
11,753
+5,859
+99% +$593K 0.11% 201
2020
Q3 		$417K Buy
+5,894
New +$411K 0.04% 486

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wedbush Securities's MRNA Position: Q1 2025 in Review

Wedbush Securities sold out of Moderna (MRNA) in Q1 2025, closing a stake of 5,902 shares — an estimated $245K sold.

Wedbush Securities first reported a position in MRNA in Q3 2020 and held it in 18 quarters. The position peaked at $2.25M in Q3 2021. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Wedbush Securities reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Wedbush Securities sold 5,902 Moderna shares in Q1 2025, an estimated $245K.
  • Wedbush Securities first reported a position in Moderna in Q3 2020 and held it in 18 quarters.
  • Wedbush Securities's Moderna position peaked at $2.25M in Q3 2021.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Wedbush Securities's 13F filing for Q1 2025, filed 6 May 2025.